REYON Pharmaceutical Co., Ltd. (KRX:102460)

REYON Pharmaceutical Revenue

REYON Pharmaceutical had revenue of 37.58B KRW in the quarter ending September 30, 2025, a decrease of -1.86%. This brings the company's revenue in the last twelve months to 149.34B, down -0.33% year-over-year. In the year 2024, REYON Pharmaceutical had annual revenue of 148.30B, down -1.83%.

• Revenue (ttm): 149.34B
• Revenue Growth: -0.33%
• P/S Ratio: 1.34
• Revenue / Employee: 339.42M
• Employees: 312
• Market Cap: 199.55B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	148.30B	-2.77B	-1.83%
Dec 31, 2023	151.07B	-2.97B	-1.93%
Dec 31, 2022	154.04B	11.24B	7.87%
Dec 31, 2021	142.80B	12.77B	9.82%
Dec 31, 2020	130.03B	-1.52B	-1.16%